Literature DB >> 27430710

A practical Bayesian stepped wedge design for community-based cluster-randomized clinical trials: The British Columbia Telehealth Trial.

Kristen M Cunanan1, Bradley P Carlin2, Kevin A Peterson3.   

Abstract

BACKGROUND: Many clinical trial designs are impractical for community-based clinical intervention trials. Stepped wedge trial designs provide practical advantages, but few descriptions exist of their clinical implementational features, statistical design efficiencies, and limitations.
OBJECTIVES: Enhance efficiency of stepped wedge trial designs by evaluating the impact of design characteristics on statistical power for the British Columbia Telehealth Trial.
METHODS: The British Columbia Telehealth Trial is a community-based, cluster-randomized, controlled clinical trial in rural and urban British Columbia. To determine the effect of an Internet-based telehealth intervention on healthcare utilization, 1000 subjects with an existing diagnosis of congestive heart failure or type 2 diabetes will be enrolled from 50 clinical practices. Hospital utilization is measured using a composite of disease-specific hospital admissions and emergency visits. The intervention comprises online telehealth data collection and counseling provided to support a disease-specific action plan developed by the primary care provider. The planned intervention is sequentially introduced across all participating practices. We adopt a fully Bayesian, Markov chain Monte Carlo-driven statistical approach, wherein we use simulation to determine the effect of cluster size, sample size, and crossover interval choice on type I error and power to evaluate differences in hospital utilization.
RESULTS: For our Bayesian stepped wedge trial design, simulations suggest moderate decreases in power when crossover intervals from control to intervention are reduced from every 3 to 2 weeks, and dramatic decreases in power as the numbers of clusters decrease. Power and type I error performance were not notably affected by the addition of nonzero cluster effects or a temporal trend in hospitalization intensity. CONCLUSION/LIMITATIONS: Stepped wedge trial designs that intervene in small clusters across longer periods can provide enhanced power to evaluate comparative effectiveness, while offering practical implementation advantages in geographic stratification, temporal change, use of existing data, and resource distribution. Current population estimates were used; however, models may not reflect actual event rates during the trial. In addition, temporal or spatial heterogeneity can bias treatment effect estimates.
© The Author(s) 2016.

Entities:  

Keywords:  Bayesian analysis; community-based interventions; comparative effectiveness research; pragmatic clinical trials; stepped wedge design

Mesh:

Year:  2016        PMID: 27430710      PMCID: PMC4957138          DOI: 10.1177/1740774516656583

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  31 in total

1.  Practice-based research--"Blue Highways" on the NIH roadmap.

Authors:  John M Westfall; James Mold; Lyle Fagnan
Journal:  JAMA       Date:  2007-01-24       Impact factor: 56.272

2.  Understanding change in primary care practice using complexity theory.

Authors:  W L Miller; B F Crabtree; R McDaniel; K C Stange
Journal:  J Fam Pract       Date:  1998-05       Impact factor: 0.493

3.  Quasi-experimental designs in practice-based research settings: design and implementation considerations.

Authors:  Margaret A Handley; Dean Schillinger; Stephen Shiboski
Journal:  J Am Board Fam Med       Date:  2011 Sep-Oct       Impact factor: 2.657

4.  Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis.

Authors:  Steven E Bellan; Juliet R C Pulliam; Carl A B Pearson; David Champredon; Spencer J Fox; Laura Skrip; Alison P Galvani; Manoj Gambhir; Ben A Lopman; Travis C Porco; Lauren Ancel Meyers; Jonathan Dushoff
Journal:  Lancet Infect Dis       Date:  2015-04-14       Impact factor: 25.071

Review 5.  The stepped wedge trial design: a systematic review.

Authors:  Celia A Brown; Richard J Lilford
Journal:  BMC Med Res Methodol       Date:  2006-11-08       Impact factor: 4.615

Review 6.  Logistic, ethical, and political dimensions of stepped wedge trials: critical review and case studies.

Authors:  Audrey Prost; Ariella Binik; Ibrahim Abubakar; Anjana Roy; Manuela De Allegri; Christelle Mouchoux; Tobias Dreischulte; Helen Ayles; James J Lewis; David Osrin
Journal:  Trials       Date:  2015-08-17       Impact factor: 2.279

7.  Designing a stepped wedge trial: three main designs, carry-over effects and randomisation approaches.

Authors:  Andrew J Copas; James J Lewis; Jennifer A Thompson; Calum Davey; Gianluca Baio; James R Hargreaves
Journal:  Trials       Date:  2015-08-17       Impact factor: 2.279

8.  Stepped-wedge cluster randomised controlled trials: a generic framework including parallel and multiple-level designs.

Authors:  Karla Hemming; Richard Lilford; Alan J Girling
Journal:  Stat Med       Date:  2014-10-24       Impact factor: 2.373

9.  Study protocol of a mixed-methods evaluation of a cluster randomized trial to improve the safety of NSAID and antiplatelet prescribing: data-driven quality improvement in primary care.

Authors:  Aileen Grant; Tobias Dreischulte; Shaun Treweek; Bruce Guthrie
Journal:  Trials       Date:  2012-08-28       Impact factor: 2.279

Review 10.  Sample size calculation for a stepped wedge trial.

Authors:  Gianluca Baio; Andrew Copas; Gareth Ambler; James Hargreaves; Emma Beard; Rumana Z Omar
Journal:  Trials       Date:  2015-08-17       Impact factor: 2.279

View more
  2 in total

1.  Evaluating the performance of Bayesian and restricted maximum likelihood estimation for stepped wedge cluster randomized trials with a small number of clusters.

Authors:  Kelsey L Grantham; Jessica Kasza; Stephane Heritier; John B Carlin; Andrew B Forbes
Journal:  BMC Med Res Methodol       Date:  2022-04-13       Impact factor: 4.615

2.  Pragmatic cluster randomized trial to evaluate effectiveness and implementation of enhanced EHR-facilitated cancer symptom control (E2C2).

Authors:  Lila J Finney Rutten; Kathryn J Ruddy; Linda L Chlan; Joan M Griffin; Jeph Herrin; Aaron L Leppin; Deirdre R Pachman; Jennifer L Ridgeway; Parvez A Rahman; Curtis B Storlie; Patrick M Wilson; Andrea L Cheville
Journal:  Trials       Date:  2020-06-05       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.